Role of TRPV1 in respiratory disease and association with traditional Chinese medicine: A literature review

Biomed Pharmacother. 2022 Nov:155:113676. doi: 10.1016/j.biopha.2022.113676. Epub 2022 Sep 8.

Abstract

Transient receptor potential vanilloid type 1 (TRPV1), involved in multiple pathophysiological processes including inflammation, is a thermally activated, non-selective cation channel. It has been identified that TRPV1 is highly involved in some common respiratory diseases including allergic rhinitis, asthma, chronic obstructive pulmonary disease, and pulmonary infection by participating in neurogenic and immunogenic inflammation, sensitization, and oxidative stress. In recent years, the hypothesis of transient receptor potential (TRP) has been introduced in studies on the theory of five flavors and four properties of Chinese medicinal. However, the hypothesis is undetermined due to the multi-component and multi-target characteristics of Chinese medicinal. This study describes the relations between TRPV1 and four types of respiratory diseases based on the literature in recent five years. In the meantime, the therapeutic effect of Chinese medicinal by intervening TRPV1 was reviewed, in an attempt to provide certain evidence for future studies on the medicinal property-effect relationship, mechanism of drug action, the syndrome differentiation in traditional Chinese medicine (TCM) for respiratory diseases and to help for new drug development.

Keywords: Allergic rhinitis; Asthma; Chronic obstructive pulmonary disease; Pulmonary infection; TRPV1; Traditional Chinese medicine.

Publication types

  • Review

MeSH terms

  • Asthma* / drug therapy
  • Humans
  • Inflammation
  • Medicine, Chinese Traditional
  • Respiratory Tract Diseases* / drug therapy
  • TRPV Cation Channels

Substances

  • TRPV Cation Channels
  • TRPV1 protein, human